Clinical and immune response to undiluted and diluted smallpox vaccine

Swiss Medical Weekly

Volumn 138, Issue 27-28, 2008, Pages 392-397

  Gassmann, R ^a   Engler, O B ^b   Steffen, R ^a   Alex, M ^c   Czerny, C P ^d   Mutsch, Margot ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Labor Spiez   (Switzerland)

^c Bavarian Animal Health Service   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adverse events; Neutralizing antibodies; Smallpox vaccine; Take rate; Vaccinia

Indexed keywords

SMALLPOX VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEVER; HEADACHE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MYALGIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SMALLPOX; SMALLPOX VIRUS; TREATMENT OUTCOME; VACCINATION;

EID: 47949086410     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organization (WHO). Declaration of global eradication of smallpox. Wkly epidemiol Rec. 1980;55:148.
2. Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281:2127-37.
3. Mahy BW. An overview on the use of a viral pathogen as a bioterrorism agent: why smallpox? Antiviral Res. 2003;57(12):1-5.
4. Alibek K. Smallpox: a disease and a weapon. Im J Infect Dis. 2004;8(Suppl)2:S3-8.
5. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9(9):1131-7.
6. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, et al; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346(17):1265-74.
7. Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, et al. Dose-related effects of smallpox vaccine. N Engl J Med. 2002;346(17):1275-80.
8. Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB. Response to smallpox vaccine in persons immunized in the distant past. JAMA. 2003;289(24):3295-9. Erratum in: JAMA. 2003;290(3):334.
9. Treanor J, Wu H, Liang H, Topham DJ. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. Vaccine. 2006;24(47-48):6913-23.
10. Talbot TR, Stapleton JT, Brady RC, et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccinee: a randomized controlled trial. JAMA. 2004;292:1205-12.
11. Orr N, Forman M, Marcus H, Lustig S, Paran N, Grotto I, et al. Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus. J Infect Dis. 2004;190(7):1295-302.
12. Kim SH, Yeo SG, Jang HC, Park WB, Lee CS, Lee KD, et al. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis. 2005;192(6):1066-70.
13. Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, et al. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain. Vaccine. 2006;24(4):510-5.
14. Centers for Disease Control and Prevention (CDC). Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.2001;50(RR-10):1-25.
15. Talbot TR, Peters J, Yan L, Wright PF, Edwards KM. Optimal bandaging of smallpox vaccination sites to decrease the potential for secondary vaccinia transmission without impairing lesion healing. Infect Control Hosp Epidemiol. 2006;27:1184-92.
16. Centers for Disease Control and Prevention (CDC). Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52(RR-07):1-16.
17. Czerny CP, Zeller-Lue C, Eis-Hübinger AM, Kaaden OR, Meyer H. Characterization of a cowpox-like orthopox virus which had caused a letal infection in man. Arch Virol. 1997;(Suppl)13:13-24.
18. Leparc-Goffart I, Poirier B, Garin D, Tissier MH, Fuchs F, Crance JM. Standardization of neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation. J Clin Virol. 2005;32:47-52.
19. Centers for Disease Control and Prevention (CDC). Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep. 2006;55(RR-1):1-16.
20. Couch RB, Winokur P, Edwards KM, Black S, Atmar RL, Stapleton JT, et al; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group. Reducing the Dose of Smallpox Vaccine Reduces Vaccine-Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses. J Infect Dis. 2007;195:826-32.
21. Espmark JA. Smallpox vaccination studies with serial dilutions of vaccine. Acta Pathol Microbiol Scand. 1965;63:97-115.
22. Worthington M. Role of antibody in recovery from severe vaccinia virus infection. Clin Infect Dis. 2003;37:864-5.
23. Baggs J, Chen RT, Damon IK, Rotz L, Allen C, Fullerton KE, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis. 2005;40(8):1133-40.
24. Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA. 2005;294(21):2734-43.
25. Vellozzi C, Averhoff F, Lane JM, Wen X, Moore AC, Santibanez S, et al. Superinfection following smallpox vaccination (Vaccinia), United States: surveillance January 2003 through January 2004. Clin Infect Dis. 2004;39(11):1660-6. Erratum in: Clin Infect Dis 2005;40(8):1214.
26. Neff JM, Lane JM, Pert JH, Moore R, Millar JD, Henderson DA. Complications of smallpox vaccination. I. National survey in the United States, 1963. N Engl J Med. 1967;276(3):125-32.
27. Malone JD. Pre-event smallpox vaccination for healthcare workers revisited - the need for a carefully screened multidisciplinary cadre. Int J Infect Dis. 2007;11:93-7.